Evaluation of resources for analyzing drug interactions
Open accessAbstract
Objective The research sought to evaluate seven drug information resources, specifically designed for analyzing drug interactions for scope, completeness, and ease of use, and determine the consistency of content among the seven resources. Methods A cross-sectional study was conducted where 100 drug-drug and drug-dietary supplement interactions were analyzed using 7 drug information resources: Lexicomp Interactions module, Micromedex Drug Interactions, Clinical Pharmacology Drug Interaction Report, Facts & Comparisons eAnswers, Stockley's Drug Interactions (10th edition), Drug Interactions Analysis and Management (2014), and Drug Interaction Facts (2015). The interaction sample was developed based on published resources and peer input. Two independent reviewers gathered data for each interaction from each of the 7 resources using a common form. Results Eighty-two drug-drug and 18 drug-dietary supplement interactions were analyzed. Scope scores were higher for Lexicomp Interactions (97.0%), Clinical Pharmacology Drug Interaction Report (97.0%), and Micromedex Drug Interactions (93.0%) compared to all other resources ( p p p p Conclusions Clinical Pharmacology Drug Interaction Report, Lexicomp Interactions, and Micromedex Drug Interactions scored highest in scope. Micromedex Drug Interactions and Lexicomp Interactions scored highest in completeness. Consistency scores were overall low, but Micromedex Drug Interactions was the highest.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
When additional information was needed, panel members could consult three drug interaction compendia, Lexicomp, Micromedex and Stockley's Drug Interactions, as supporting knowledge sources.
“When additional information was needed, panel members could consult three drug interaction compendia (Lexicomp, Micromedex and Stockley's Drug Interactions) as supporting knowledge sources [37,38].”
From Comparing Artificial Intelligence (ChatGPT, Gemini, DeepSeek) and Oral Surgeons in Detecting Clinically Relevant Drug–Drug Interactions in Dental Therapy (2025) · cites this paper as [38]
Cites
Malone, D. C., Armstrong, E. P., Abarca, J., Grizzle, A. J., Hansten, P. D., Bergen, R. C. V., Duncan, B. S., Solomon, S. L., & Lipton, R. B. (2004) · Journal of the American Pharmacists Association · doi:10.1331/154434504773062591 · Cited by 187 · see citing works
Clinical decision support tools: analysis of online drug information databases
Clauson, K. A., Marsh, W. A., Polen, H. H., Seamon, M. J., & Ortiz, B. I. (2007) · BMC Medical Informatics and Decision Making · doi:10.1186/1472-6947-7-7 · Cited by 118 · see citing works
Drug Interactions Analysis and Management 2009
Ranieri, M. (2009) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181c0d593 · Cited by 78 · see citing works
Ingrim, N. B. (1984) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/41.4.822 · Cited by 75 · see citing works
Stott, P. (2004) · International Journal of Clinical Practice · doi:10.1111/j.1368-5031.2004.0145.x · Cited by 73 · see citing works
Malone, D. C., Abarca, J., Hansten, P. D., Grizzle, A. J., Armstrong, E. P., Bergen, R. C. V., Duncan, B. S., Solomon, S. L., & Lipton, R. B. (2005) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2005.05.001 · Cited by 40 · see citing works
Polen, H. H., Zapantis, A., Clauson, K. A., Jebrock, J., & Paris, M. (2008) · BMC Infectious Diseases · doi:10.1186/1471-2334-8-153 · Cited by 38 · see citing works
Pharmacists’ Patient Care Process
O’Connor, S. K. (2015) · The American Pharmacists Association eBooks · doi:10.21019/preceptor.1001.13 · Cited by 32 · see citing works
Clinical Approach to Adverse Events and Interactions Related to Herbal and Dietary Supplements
HALLER, C. A. (2006) · Clinical Toxicology · doi:10.1080/15563650600795545 · Cited by 20 · see citing works
Practical Pointers: Clinically important drug-drug interactions and how to manage them*
Bryant, L. J. M., & Fishman, T. (2009) · Journal of Primary Health Care · doi:10.1071/hc09150 · Cited by 5 · see citing works
Flagged first, then by citations
1 of the 11 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
The role of pharmacogenomics in adverse drug reactions
Cacabelos, R., Cacabelos, N., & Carril, J. C. (2019) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2019.1597706 · Cited by 113 · see citing works
Ismail, M., Khan, S., Khan, F., Noor, S., Sajid, H., Yar, S., & Rasheed, I. (2020) · BMC Cancer · doi:10.1186/s12885-020-06855-9 · Cited by 94 · see citing works
Risk factors for potential drug-drug interactions in intensive care unit patients
Јаnkovic, S., Pejčić, A. V., Milosavljević, M. N., Opančina, V., Pešić, N. V., Nedeljkovic, T., & Babić, G. M. (2017) · Journal of Critical Care · doi:10.1016/j.jcrc.2017.08.021 · Cited by 70 · see citing works
Plasencia-García, B. O., Rodríguez-Menéndez, G., Rico-Rangel, M. I., Rubio-García, A., Torelló-Iserte, J., & Crespo‐Facorro, B. (2021) · Psychopharmacology · doi:10.1007/s00213-020-05716-4 · Cited by 61 · see citing works
Pharmacogenomics of Cognitive Dysfunction and Neuropsychiatric Disorders in Dementia
Cacabelos, R. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093059 · Cited by 61 · see citing works
A Scoping Review of the Evidence Behind Cytochrome P450 2D6 Isoenzyme Inhibitor Classifications
Cicali, E. J., Smith, D. M., Duong, B. Q., Kovar, L., Cavallari, L. H., & Johnson, J. A. (2020) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1768 · Cited by 53 · see citing works
Cacabelos, R. (2020) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2020.1779700 · Cited by 50 · see citing works
A comparison of potential psychiatric drug interactions from six drug interaction database programs
Monteith, S., & Glenn, T. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.03.041 · Cited by 47 · see citing works
Magro, L., Arzenton, E., Leone, R., Stano, M. G., Vezzaro, M., Rudolph, A., Castagna, I., & Moretti, U. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.622862 · Cited by 50 · see citing works
Direct-acting oral anticoagulants (DOACs) in pregnancy: new insight from VigiBase®
Sessa, M., Mascolo, A., Callréus, T., Capuano, A., Rossi, F., & Andersen, M. T. (2019) · Scientific Reports · doi:10.1038/s41598-019-43715-4 · Cited by 44 · see citing works
Santos-Díaz, G., Pico, A. M. P., Suárez-Santisteban, M. Á., García-Bernalt, V., Mayordomo, R., & Dorado, P. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12080713 · Cited by 42 · see citing works
Ismail, M., Aziz, S., Noor, S., Haider, I., Shams, F., Haq, I., Khadim, F., Khan, Q., Khan, F., & Asif, M. (2017) · Journal of Critical Care · doi:10.1016/j.jcrc.2017.04.028 · Cited by 38 · see citing works
Suriyapakorn, B., Chairat, P., Boonyoprakarn, S., Rojanarattanangkul, P., Pisetcheep, W., Hunsakunachai, N., Vivithanaporn, P., Wongwiwatthananukit, S., & Khemawoot, P. (2019) · PLoS ONE · doi:10.1371/journal.pone.0225239 · Cited by 37 · see citing works
Annotation and detection of drug effects in text for pharmacovigilance
Thompson, P., Daikou, S., Ueno, K., Batista-Navarro, R., Tsujii, J., & Ananiadou, S. (2018) · Journal of Cheminformatics · doi:10.1186/s13321-018-0290-y · Cited by 32 · see citing works
Choi, Y. H., Lee, I. H., Yang, M., Cho, Y. S., Jo, Y. H., Bae, H. J., Kim, Y. S., & Park, J. D. (2021) · PLoS ONE · doi:10.1371/journal.pone.0246754 · Cited by 28 · see citing works
Shariff, A., Sridhar, S. B., Basha, N. F. A., Alshemeil, S. S. H. B. T., & Alzaabi, N. A. A. A. (2021) · Cureus · doi:10.7759/cureus.13766 · Cited by 28 · see citing works
Khan, Q., Ismail, M., Haider, I., & Khan, F. (2017) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-017-0532-5 · Cited by 27 · see citing works
Consistency of psychotropic drug–drug interactions listed in drug monographs
Liu, X., Hatton, R. C., Zhu, Y., Hincapie‐Castillo, J. M., Bussing, R., Barnicoat, M., & Winterstein, A. G. (2017) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2017.07.008 · Cited by 25 · see citing works
Biscaglia, G., Piazzolla, M., Cocomazzi, F., Melchionda, G., Cata, A. D., Bossa, F., Palmieri, O., & Andriulli, A. (2020) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000001919 · Cited by 23 · see citing works
Liu, Y., Wang, J., Gong, H., Li, C., Wu, J., Xia, T., Li, C., Li, S., & Chen, M. (2023) · Annals of Translational Medicine · doi:10.21037/atm-22-5463 · Cited by 22 · see citing works
Making Polypharmacy Safer for Children with Medical Complexity
Feinstein, J. A., & Orth, L. E. (2022) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2022.10.012 · Cited by 20 · see citing works
Kalash, A., Abdelrahman, A., Al-Zakwani, I., & Suleimani, Y. A. (2023) · Drugs - Real World Outcomes · doi:10.1007/s40801-023-00373-3 · Cited by 14 · see citing works
Torres‐Carrillo, N., Martínez‐López, E., Torres-Carrillo, N. M., López-Quintero, A., Moreno-Ortíz, J. M., González‐Mercado, A., & Gutiérrez-Hurtado, I. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242317100 · Cited by 17 · see citing works
Monteith, S., Glenn, T., Gitlin, M. J., & Bauer, M. (2020) · Pharmacopsychiatry · doi:10.1055/a-1156-4193 · Cited by 17 · see citing works
Thapa, R. B., Karki, S., & Shrestha, S. (2025) · Exploratory Research in Clinical and Social Pharmacy · doi:10.1016/j.rcsop.2025.100564 · Cited by 19 · see citing works
Plasencia-García, B. O., Rico-Rangel, M. I., Rodríguez-Menéndez, G., Rubio-García, A., Torelló-Iserte, J., & Crespo‐Facorro, B. (2021) · Pharmacopsychiatry · doi:10.1055/a-1492-3293 · Cited by 16 · see citing works
Drug interaction alerts in older primary care patients, and related medically justified actions
Tukukino, C., López, N. P., Svensson, S. A., & Wallerstedt, S. M. (2022) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-022-03292-4 · Cited by 15 · see citing works
Koni, A. A., Nazzal, M. A., Suwan, B. A., Sobuh, S. S., Abuhazeem, N. T., Salman, A. N., Salameh, H. T., Amer, R. A., & Zyoud, S. H. (2022) · BMC Cancer · doi:10.1186/s12885-022-09649-3 · Cited by 15 · see citing works
Assessment of Drug Interactions with Online Electronic Checkers in Multi-Pathological Patients
Roca, B., & Roca, M. (2021) · Pharmacology · doi:10.1159/000518439 · Cited by 14 · see citing works
Kim, J., Kincaid, J. W. R., Rao, A. S., Lie, W., Fuh, L., Landman, A., & Succi, M. D. (2024) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2024.102304 · Cited by 14 · see citing works
Preininger, A. M., Rosario, B. L., Buchold, A. M., Heiland, J., Kutub, N., Bohanan, B. S., South, B. R., & Jackson, G. P. (2021) · International Journal of Medical Informatics · doi:10.1016/j.ijmedinf.2021.104530 · Cited by 13 · see citing works
Tukukino, C., & Wallerstedt, S. M. (2019) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13294 · Cited by 13 · see citing works
Tayeb, S., Barausse, C., Pellegrino, G., Sansavini, M., Pistilli, R., & Felice, P. (2025) · Applied Sciences · doi:10.3390/app152312851 · Cited by 12 · see citing works
Feasibility study of a clinical decision support system for polymedicated patients in primary care
Manzanet, J. M. P., Fico, G., Barbancho, B. M., Hernández, L., Vera‐Muñoz, C., Seara, G., Torrego-Ellacuría, M., Luengo, H. G., Wastesson, J. W., Fastbom, J., et al. (2023) · Healthcare Technology Letters · doi:10.1049/htl2.12046 · Cited by 13 · see citing works
Morte-Romea, E., Gómez, P. L., MENDOZA, M. A., Sierra-Monzón, J. L., Pueyo, A. M. C., Pellejero-Sagastizábal, G., Muñoz, G., Fabra, D. S., & Paño‐Pardo, J. R. (2020) · Antibiotics · doi:10.3390/antibiotics9010019 · Cited by 11 · see citing works
Tukukino, C., Eriksson, A. L., Hamdan, W. F., Hybelius, F. W., & Wallerstedt, S. M. (2023) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13843 · Cited by 9 · see citing works
Herb-drug interaction resources: The PHYDGI database
Perrot, J. D., Bennetau‐Pelissero, C., Miremont‐Salamé, G., Petitet, F., Cluzet, S., Peyrouzet, H., & Létinier, L. (2022) · Phytomedicine Plus · doi:10.1016/j.phyplu.2022.100324 · Cited by 9 · see citing works
Laban, A., Birand, N., Chukwunyere, U., Abdi, A. M., & Başgut, B. (2021) · Nigerian Journal of Clinical Practice · doi:10.4103/njcp.njcp_266_20 · Cited by 9 · see citing works
Polypharmacy and Cardiovascular Diseases: Consideration for Older Adults and Women
Patel, S., Kumar, M., Beavers, C. J., Karamat, S., & Alenezi, F. A. M. (2022) · Current Atherosclerosis Reports · doi:10.1007/s11883-022-01055-1 · Cited by 9 · see citing works
Evaluation of drug information resources for drug-ethanol and drug-tobacco interactions
Beckett, R. D., Stump, C. D., & Dyer, M. A. (2019) · Journal of the Medical Library Association JMLA · doi:10.5195/jmla.2019.549 · Cited by 9 · see citing works
Self-citationSahoo, A. K., Singh, A. D., Gupta, D., Dhaneria, S., & Arunima, P. (2023) · Hospital Pharmacy · doi:10.1177/00185787231182569 · Cited by 8 · see citing works
Quah, K. S.-E., Huang, X., Rénia, L., & Oon, H. H. B. (2022) · Annals of the Academy of Medicine Singapore · doi:10.47102/annals-acadmedsg.2022289 · Cited by 8 · see citing works
Aksoyalp, Z. Ş., & Erdoğan, B. R. (2024) · Ankara Universitesi Eczacilik Fakultesi Dergisi · doi:10.33483/jfpau.1460173 · Cited by 8 · see citing works
Sessa, M., Mascolo, A., Dalhoff, K., & Andersen, M. T. (2020) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2020.1711882 · Cited by 8 · see citing works
Drug-Drug Interactions in Hepatitis Patients: Do these Interactions Matter in Clinical Perspectives?
Noor, S., Ismail, M., Haider, I., & Khadim, F. (2018) · Annals of Hepatology · doi:10.5604/01.3001.0012.7200 · Cited by 7 · see citing works
Sessa, M., Mascolo, A., Rasmussen, D. B., Kragholm, K. H., Jensen, M. T., Sportiello, L., Rafaniello, C., Tari, G. M., Pagliaro, C., Andersen, M. T., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-47967-y · Cited by 7 · see citing works
Beckett, R. D., Martin, J. R., Stump, C. D., & Dyer, M. A. (2020) · Journal of the Medical Library Association JMLA · doi:10.5195/jmla.2020.969 · Cited by 7 · see citing works
Self-citationDeprescribing in Older Poly-Treated Patients Affected with Dementia
Gareri, P., Gallelli, L., Gareri, I., Rania, V., Palleria, C., & Sarro, G. D. (2024) · Geriatrics · doi:10.3390/geriatrics9020028 · Cited by 6 · see citing works
Wang, W., Xiao, B., Liu, Z., Wang, D., & Zhu, M. (2019) · Iranian Journal of Public Health · doi:10.18502/ijph.v48i3.886 · Cited by 6 · see citing works
Shareef, J., Sridhar, S. B., Thomas, S., Shariff, A., & Chalasani, S. H. (2021) · Cureus · doi:10.7759/cureus.20319 · Cited by 5 · see citing works
Shen, L., Wang, J., Yi, Y., Ye, C., Wang, R., Xia, G., Yu, C., Tu, F., Xu, J., & Zheng, Z. (2018) · Drug Testing and Analysis · doi:10.1002/dta.2534 · Cited by 4 · see citing works
Kasim, H. F. (2023) · Journal of Pharmacy & Pharmacognosy Research · doi:10.56499/jppres23.1577_11.2.281 · Cited by 4 · see citing works
Rahmadani, I., Irawati, S., Wibowo, Y. I., & Setiadi, A. P. (2023) · PeerJ · doi:10.7717/peerj.15072 · Cited by 4 · see citing works
Sahilu, T., Getachew, M., Melaku, T., Sheleme, T., Abu, D., & Zewdu, T. (2021) · Scientific Reports · doi:10.1038/s41598-021-91281-5 · Cited by 4 · see citing works
Uribe-Cavero, L. J., Vera-Maccha, P. J., Siguas-Huasasquiche, A., Bohorquez-Espino, E. E., & Taype-Rondán, Á. (2025) · Journal of Evidence-Based Integrative Medicine · doi:10.1177/2515690x251334445 · Cited by 3 · see citing works
Boonyarattanasoonthorn, T., Khemawoot, P., & Kijtawornrat, A. (2021) · Veterinary Sciences · doi:10.3390/vetsci8040060 · Cited by 3 · see citing works
Hulskotte, L. M. G., Töpfer, W., Reyners, A. K. L., Taxis, K., & Jansman, F. G. A. (2024) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-023-03612-2 · Cited by 3 · see citing works
Al-Ashwal, F. Y., Sulaiman, S. A. S., Ghadzi, S. M. S., Kubas, M. A., & Halboup, A. M. (2022) · Current Medical Research and Opinion · doi:10.1080/03007995.2022.2072088 · Cited by 3 · see citing works
Off-label use information in electronic drug information resources
Rothgeb, A., Beckett, R. D., & Daoud, N. (2023) · Journal of the Medical Library Association JMLA · doi:10.5195/jmla.2022.1419 · Cited by 3 · see citing works
Self-citationHan, F., Cheng, X., Li, Y., Bai, J., Dong, L., & Wang, J. (2025) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2025.2511961 · Cited by 2 · see citing works
Gibson, B. N., Chodapuneedi, S., Koh, H. Y., Gupta, S., Gašević, D., Wang, A. Y., Marzolini, C., Khoo, S., Romero, L., Dalli, L. L., et al. (2026) · British Journal of Pharmacology · doi:10.1111/bph.70515 · Cited by 2 · see citing works
Evaluation of Point-of-Care Resources for Dietary Supplement Information
Montgomery, A., Beckett, R. D., Montagano, K. J., & Kutom, S. (2018) · Journal of Evidence-Based Integrative Medicine · doi:10.1177/2515690x18764844 · Cited by 2 · see citing works
Self-citationPotential Drug-Drug Interactions in Critically Ill Medical Patients: A Cross-Sectional Study
Hosseini, E., Shojaei, L., Karimpour, H., & Shahbazi, F. (2019) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 2 · see citing works
Potenciais interações medicamentosas em adultos e idosos no ambiente hospitalar
Ulbrich, A. H. D. P. S., Oliveira, J. D., Couto, J., ORTIZ, G. X., & Isoppo, C. S. (2023) · Revista Brasileira de Farmácia Hospitalar e Serviços de Saúde · doi:10.30968/rbfhss.2023.143.0971 · Cited by 2 · see citing works
Nano therapy Spotlight: Arestin™ Minocycline Microspheres
Plemmons, D. G., Sneed, K. B., & Pathak, Y. V. (2023) · Chemical & Pharmaceutical Research · doi:10.33425/2689-1050.1046 · Cited by 2 · see citing works
Identifying Experimental Evidence in Biomedical Abstracts Relevant to Drug-Drug Interactions
Zhang, G., Roychowdhury, D., Li, P., Wu, H., Zhang, S., Li, L., & Shatkay, H. (2018) · ACM International Conference on Bioinformatics, Computational Biology, and Health Informatics (ACM-BCB) · doi:10.1145/3233547.3233568 · Cited by 1 · see citing works
Aleksić, D., Stefanović, S., Milosavljević, M. N., Milosavljevic, J. Z., & Јаnkovic, S. (2021) · Hospital Pharmacology - International Multidisciplinary Journal · doi:10.5937/hpimj2103099a · Cited by 1 · see citing works
Introduction to Drug-Drug Interactions
Pai, M. P., Kiser, J. J., Gubbins, P. O., & Rodvold, K. A. (2018) · Springer eBooks · doi:10.1007/978-3-319-72422-5_1 · Cited by 1 · see citing works
Guiding principles for evaluating tertiary health care resources: The A2C2QUIRE framework
Phillips, J. A., Hanrahan, C. T., Brown, J. N., May, D. W., Britnell, S. R., & Ficzere, C. (2019) · JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY · doi:10.1002/jac5.1176 · Cited by 1 · see citing works
Self‐management recommendations for sickle cell disease: A content analysis of websites
Druye, A. A., Nelson, K., & ROBINSON, B. J. (2020) · Nursing and Health Sciences · doi:10.1111/nhs.12741 · Cited by 1 · see citing works
Bosetto, A., da Silva, C. M., & de Peder, L. D. (2020) · Journal Health NPEPS · Cited by 1 · see citing works
Comparing potential drug-drug interactions in veterinary medications using two electronic databasesPreprint
Boonyarattanasoonthorn, T., Khemawoot, P., & Kijtawornrat, A. (2020) · doi:10.21203/rs.3.rs-23037/v2 · Cited by 1 · see citing works
Comparing Potential Drug-Drug Interactions in Veterinary Medications Using Two Electronic DatabasesPreprint
Kijtawornrat, A., Boonyarattanasoonthorn, T., & Khemawoot, P. (2020) · doi:10.21203/rs.3.rs-23037/v1
Pedersen, H. K., Sørensen, A. M. S., Schelde, A. B., Nyeland, M. E., & Jimenez‐Solem, E. (2021) · Adverse Drug Reaction Bulletin · doi:10.1097/fad.0000000000000057
Self‐Management Recommendations for Sickle Cell Disease: A Content Analysis of Websites
Andrews, D. A., ROBINSON, B. J., & Nelson, K. (2020) · doi:10.26686/wgtn.12470387.v3
Self‐Management Recommendations for Sickle Cell Disease: A Content Analysis of Websites
Andrews, D. A., Nelson, K., & Brian, R. (2020) · doi:10.26686/wgtn.12470387.v2
Unnissa, Z., Naseer, F., & Begum, M. (2023) · International Journal of Pharmaceutical Sciences Review and Research · doi:10.47583/ijpsrr.2023.v80i01.006
Oral COVID-19 Antiviral Agents in Dermatology Outpatient Treatment
Quah, K. S.-E., Huang, X., Rénia, L., & Oon, H. H. B. (2023) · Updates in clinical dermatology · doi:10.1007/978-3-031-45586-5_14
Alhumaid, M. S., Almalki, F. M., Alsayyali, A. M., Alshamrani, G. A., Alotaibi, A. Z., Gethami, A. A. A., Alqarni, M. A., Alqarni, M. A., Alhosayni, S. A., Alsukhayri, O. M., et al. (2023) · doi:10.53555/jptcp.v30i2.4985
Methodology for Creating a Risk Management System for Drug-Drug Interactions
Таубэ, А. А., & Zhuravleva, M. V. (2024) · Antibiot Khimioter = Antibiotics and Chemotherapy · doi:10.37489/0235-2990-2023-68-11-12-49-58
Diagnostic Interviewing and Cognitive Screening
Martin, P. K., Surineni, K., & Schroeder, R. W. (2024) · doi:10.1093/med/9780197690024.003.0003
Zhdanava, M., Burbage, S. C., Totev, T. I., Kachroo, S., Diaz, L., Godwin, B. C., Lefèbvre, P., & Pilon, D. (2025) · Current Medical Research and Opinion · doi:10.1080/03007995.2025.2465649
Eguale, T., Mirica, M., Salazar, A., Shilka, J., Galanter, W., Cashy, J., Gellad, W. F., Hale, J. A., Lambert, B. L., Mohamed, A. F. S., et al. (2025) · Journal of General Internal Medicine · doi:10.1007/s11606-025-09455-0
Yaowaluk, T., Tangpanithandee, S., Techapichetvanich, P., & Khemawoot, P. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s543827
ALAM, A., Saran, A., JOSHI, R., Sridhar, S. B., Sharma, S. K., & Paliwal, S. (2025) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2025v17i5.54398
Potential Drug Interactions in Liver Cirrhosis: Patterns and Sociodemographic Factors
Amni, H., Fitria, N., & Sari, Y. O. (2025) · Journal of Pharmaceutical And Sciences · doi:10.36490/journal-jps.com.v8i3.910
Ismail, M., Khan, S., Khan, F., Noor, S., Sajid, H., Yar, S., & Rasheed, I. (2020) · Figshare · doi:10.6084/m9.figshare.12154152
Drug interaction dilemmas: A database-based comparative evaluation of dual antihypertensive therapy
Alam, A., Dubey, P., Joshi, R., Sridhar, S. B., & Sharma, S. (2026) · In Silico Research in Biomedicine · doi:10.1016/j.insi.2026.100216
Khan, M. A., Syafhan, N. F., Noor, S., Alshammari, M. S., Otaibi, M., Alrohily, W., Alanazi, A. H. A., Alsubhi, W. A., Shammari, L. A. A., Imran, M. R., et al. (2026) · Healthcare · doi:10.3390/healthcare14091224
Thuc, A. P. D., Vo, T. H., Luu, T. N. N., Ngo, H. T. T., Heinrich, M., & Kongkaew, C. (2026) · PLoS ONE · doi:10.1371/journal.pone.0355046
Deciphering Mechanistic Signatures in Drug-Drug Interactions with Dual Topology GraphsPreprint
Ma, W., Bi, X., Jiang, H., Lu, W., Nie, J., Lin, S., Lin, J., Wei, Z., Zhang, H., & Zhang, S. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.09.23.753684
Nguyen, N. T. L., Le, Q. N. T., Le, T. T. C., & Nguyen, T. (2026) · Journal of Research in Pharmacy Practice · doi:10.4103/jrpp.jrpp_47_26
Koech, B., & Terefe, E. M. (2026) · Health Science Reports · doi:10.1002/hsr2.73356
- Authors
- Patel, R. I., & Beckett, R. D.
- Affiliations
- University of Arizona (US)
- University of Manchester (GB)
- ORCID
- Beckett, Robert D.
- Venue
- Journal of the Medical Library Association : JMLA
- Published
- 2016-10
- Volume
- 104
- Issue
- 4
- Pages
- 290-295
- ISSN
- 1536-5050 (ISSN-L)
- 1558-9439
- PMC
- PMC5079490
- OpenAlex
- W2551182653
- Cited by
- 97
- References
- 11
- Citations by year
- 2026: 7 · 2025: 8 · 2024: 6 · 2023: 18 · 2022: 7 · 2021: 13 · 2020: 17 · 2019: 11 · 2018: 6 · 2017: 4
- FWCI
- 8.80
- Type
- journal article
- Language
- en
- Open access
- diamond
- doi.org
- Licence
- cc-by
- Locations
- Journal of the Medical Library Association JMLA (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- UA Campus Repository (The University of Arizona) (acceptedVersion, cc-by)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacy and Medical Practices
- Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
- Health Sciences › Health Professions › Health Information Management › Electronic Health Records Systems
- Keywords
- drug interactions, drug information resources, drug-drug interactions, information resource evaluation, content consistency, completeness, ease of use
- MeSH terms
- Drug Information Services, Drug Interactions, Humans, Reference Books, Databases, Factual
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
